Status:
COMPLETED
Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)
Lead Sponsor:
Organon and Co
Conditions:
Eczema
Dermatitis
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
This is an efficacy and safety study of up to 12 weeks of desloratadine in Japanese participants with eczema/dermatitis and dermal pruritus. The primary hypothesis of this study is that the sum of the...
Eligibility Criteria
Inclusion
- Eczema/dermatitis (acute eczema, chronic eczema, contact dermatitis, atopic dermatitis, nummular eczema, seborrheic dermatitis, asteatotic eczema, neurodermatitis, etc. among eczema/dermatitis for which the observation of pruritus is appropriate)
- Dermal pruritus (generalized dermal pruritus, localized dermal pruritus)
Exclusion
- Hypersensitivity to antihistamines or ingredients of a study drug
Key Trial Info
Start Date :
August 27 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 22 2014
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT01916980
Start Date
August 27 2013
End Date
March 22 2014
Last Update
June 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.